Smithfield Foods (NasdaqGS:SFD) Q4 2025 Earnings call March 24, 2026 09:00 AM ET Company ParticipantsBenjamin Theurer - Managing DirectorChris Downey - Managing Director in Mergers & AcquisitionsDonovan Owens - European Division for Smithfield FoodsDoug Sutton - Chief Manufacturing OfficerJulie MacMedan - Vice President of Investor RelationsManav Gupta - Executive DirectorMark Hall - Chief Financial OfficerMegan Clapp - Equity ResearchShane Smith - President and Chief Executive OfficerSteven France - Presid ...

Manulife Financial (NYSE:MFC) FY Conference March 24, 2026 09:00 AM ET Company ParticipantsColin Simpson - CFOConference Call ParticipantsNone - AnalystNoneThanks for coming to Montreal again.Colin SimpsonThanks a lot, Gabe. It's time for you to relax, and I'll let you finish interviewing your CEO.NoneOh, yeah. I can loosen up a bit. I was uptight that time. Let's start with a fun one, ROE. You know.Colin SimpsonWell.NoneEvery company I cover basically is hiking their ROE targets. You were early in that pha ...

Smithfield Foods (NasdaqGS:SFD) Q4 2025 Earnings call March 24, 2026 09:00 AM ET Speaker11Good day, and welcome to the Smithfield Foods Fourth Quarter 2025 Financial Results Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad, and to withdraw yo ...

Our 2030 Vision Bladex Investor Day March 2026 Disclaimer This presentation contains forward -looking statements of expected future developments within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934 . Forward -looking statements can be identified by words such as : "anticipate", "intend", "plan", "goal", "seek", "believe", "project", "estimate", "expect", "strategy", "future", "likely", "may", "should", "will" and similar references ...

Zillow Group (NasdaqGS:Z) Update / briefing March 24, 2026 09:00 AM ET Company ParticipantsBrad Berning - VP of Investor RelationsCameron Swiggett - VP of Product ManagementCynthia Taylor - SVP of Agent Software and AdvertisingDae Lee - VP of Equity ResearchDavid Beitel - CTOJeremy Hofmann - CFOJeremy Wacksman - CEOJohn Colantuoni - Managing DirectorLloyd Frink - Co-founder and Co-Executive ChairmanMary Ellen D'Amico - Director of Investor RelationsMatt Cost - Executive DirectorMichael Sherman - SVP of Zill ...

Achieve Life Sciences (NasdaqCM:ACHV) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJaime Xinos - Chief Commercial OfficerMark Oki - CFOMark Rubinstein - CMONicole Jones - VP of Strategic Communications and Stakeholder RelationsRick Stewart - President and CEOConference Call ParticipantsBrandon Folkes - AnalystJason Butler - Managing Director and Biotechnology Equity Research AnalystJohn Vandermosten - Senior AnalystJustin Walsh - AnalystThomas Gladen - AnalystOperatorGreetings, and w ...

LENZ Therapeutics (NasdaqGS:LENZ) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsAlyssa Larios - Research AssociateDan Chevallard - CFOEvert Schimmelpennink - President and CEOMelanie Gloria - Equity Research AssociateShawn Olsson - Chief Commercial OfficerConference Call ParticipantsBrian Abrahams - Senior Research AnalystLachlan Hanbury-Brown - Equity Research AnalystMatthew Caufield - Director and Senior Biotechnology Equity Research AnalystStacy Ku - Biotech AnalystYigal Nochomovit ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeff Hackman - CEOPierre S. Sayad - Chief Medical OfficerRobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystNone - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeffrey S. Hackman - CEOPierre S. Sayad - CMORobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystSudhanva Nathan - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsAlex von Riesemann - AVP of Biotech Equity ResearchJeff Hackman - CEOPierre S. Sayad - Chief Medical OfficerRobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystSudan Loganathan - Biotechnology Equity Research AnalystOperatorGood morning, ladies ...